Paul Conyngham was very upset to discover his dog Rosie had cancer in 2024. He was working with vets to do whatever he could to extend her life. But as 2025 went on Paul realized the power of A.I. was growing. He began using it to work on curing Rosie's cancer. He paid to have her healthy and tumor DNA sequenced at the University of New South Wales. He then used AI to analyze the mutations driving the cancer and identify possible treatment targets.
A pharmaceutical company declined to provide an immunotherapy drug for compassionate use, so Conyngham worked with the university to produce a custom mRNA vaccine based on the AI-generated formula. Rosie received the first injection in December, less than two months after the vaccine sequence was finalized. By mid-March, the tennis ball-sized tumor on her leg had shrunk by about 75%, according to Conyngham. He also says Rosie’s mobility and behavior improved after the treatment.
Researchers at the University of New South Wales say this is the first example of a personalized cancer vaccine designed for a dog. The director of the university’s genomics department says the project proves the potential for similar personalized approaches in human cancer treatment.
Source: YAHOO FINANCE